Northern Trust Corp Biotechnology

Northern Trust Corp

$690 Billion
Q4 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
MAIA Maia Biotechnology, Inc.	$20.6M	$63,000 0.0% of portfolio	32,071	Q2 2024 Added 58.2%
LYRA Lyra Therapeutics, Inc.	$6.37M	$60,000 0.0% of portfolio	286,310	Q4 2024 Added 56.21%
BCAB Bio Atla, Inc.	$16.3M	$59,000 0.0% of portfolio	100,822	Q4 2024 Added 13.56%
ANTX An2 Therapeutics, Inc.	$22.1M	$58,000 0.0% of portfolio	43,196	Q4 2024 Added 32.52%
TPST Tempest Therapeutics, Inc.	$9.38M	$56,000 0.0% of portfolio	67,815	Q4 2024 Added 233.18%
CVM Cel Sci Corp	$18.2M	$47,000 0.0% of portfolio	118,312	Q2 2024 Reduced 0.06%
UNCY Unicycive Therapeutics, Inc.	$8.73M	$45,000 0.0% of portfolio	58,181	Q4 2024 Added 142.44%
RLMD Relmada Therapeutics, Inc.	$8.87M	$43,000 0.0% of portfolio	84,282	Q4 2024 Added 12.8%
LTRN Lantern Pharma Inc.	$46.5M	$40,000 0.0% of portfolio	12,813	Q2 2024 Reduced 0.08%
LEXX Lexaria Bioscience Corp.	$8.93M	$38,000 0.0% of portfolio	18,389	Q1 2024 New
XLO Xilio Therapeutics, Inc.	$26.6M	$37,000 0.0% of portfolio	39,208	Q2 2024 Added 120.29%
NXTC Next Cure, Inc.	$20.8M	$36,000 0.0% of portfolio	47,493	Q4 2024 Reduced 0.15%
ARMP Armata Pharmaceuticals, Inc.	$72.7M	$35,000 0.0% of portfolio	19,273	Q2 2024 Reduced 0.1%
CGTX Cognition Therapeutics Inc	$13.4M	$35,000 0.0% of portfolio	47,485	Q1 2024 Added 54.56%
PASG Passage Bio, Inc.	$30M	$35,000 0.0% of portfolio	62,476	Q4 2024 Added 55.1%
SPRB Spruce Biosciences, Inc.	$9.9M	$32,000 0.0% of portfolio	80,308	Q4 2024 Added 7.18%
ATHA Athira Pharma, Inc.	$17M	$31,000 0.0% of portfolio	53,609	Q2 2024 Added 0.73%
GLYC Glycomimetics Inc	$14.7M	$29,000 0.0% of portfolio	116,985	Q3 2024 Reduced 8.46%
OMGA Omega Therapeutics, Inc.	$7.18M	$29,000 0.0% of portfolio	39,706	Q3 2024 Reduced 75.9%
PMCB Pharma Cyte Biotech, Inc.	$38.6M	$29,000 0.0% of portfolio	19,208	Q2 2024 Reduced 0.11%
ADAP Adaptimmune Therapeutics PLC	$94.8M	$27,000 0.0% of portfolio	51,333	Q3 2024 Reduced 1.02%
BTAI Bio Xcel Therapeutics, Inc.	$64.5M	$27,000 0.0% of portfolio	73,910	Q4 2024 Added 81.38%
EQ Equillium, Inc.	$30.2M	$27,000 0.0% of portfolio	35,019	Q2 2024 Reduced 0.09%
BYSI Beyond Spring Inc.	$67.7M	$27,000 0.0% of portfolio	16,705	Q3 2024 Reduced 1.1%
OCUP Ocuphire Pharma, Inc.	$20.2M	$26,000 0.0% of portfolio	27,267	Q2 2024 Reduced 47.49%
INAB In8 Bio, Inc.	$6.86M	$25,000 0.0% of portfolio	93,420	Q4 2024 Added 211.35%
ACXP Acurx Pharmaceuticals, Inc.	$9.01M	$22,000 0.0% of portfolio	27,286	Q2 2024 Added 59.07%
BOLT Bolt Biotherapeutics, Inc.	$18.8M	$22,000 0.0% of portfolio	40,895	Q2 2024 Reduced 0.27%
AIM Aim Immuno Tech Inc.	$6.73M	$17,000 0.0% of portfolio	85,119	Q2 2024 Reduced 0.1%
IPA Immuno Precise Antibodies Ltd.	$10.2M	$16,000 0.0% of portfolio	41,106	Q4 2024 Reduced 18.97%
SNSE Sensei Biotherapeutics, Inc.	$14.7M	$12,000 0.0% of portfolio	25,983	Q2 2024 Reduced 0.25%
EYEN Eyenovia, Inc.	$59.5M	$9,000 0.0% of portfolio	61,486	Q3 2024 Reduced 75.5%
ONVO Organovo Holdings, Inc.	$3.31M	$9,000 0.0% of portfolio	24,806	Q2 2024 Added 69.07%
VINC Vincerx Pharma, Inc.	$26.7M	$9,000 0.0% of portfolio	34,297	Q2 2024 Reduced 0.08%
INKT Mi Nk Therapeutics, Inc.	$348M	$7,000 0.0% of portfolio	11,441	Q4 2024 Added 3.32%
VIRX Viracta Therapeutics, Inc.	$1.13M	$6,000 0.0% of portfolio	38,104	Q2 2024 Reduced 0.23%
HCWB Hcw Biologics Inc.	$14M	$4,000 0.0% of portfolio	10,205	Q2 2023 New
SBTX Silverback Therapeutics, Inc.	$0	$0 0.0% of portfolio	478,153	Q4 2024 Added 5.7%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.